| Type: |
Conjugated Primary Antibody |
| Conjugated with: |
594, ALEXA FLUOR® |
| Host organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Protein/Peptide: |
Chloramphenicol |
| Specificity: |
This antibody reacts specifically with Chloramphenicol |
| Modification: |
No modification has been applied to this antibody |
| Modification site: |
None |
| Clonality: |
Polyclonal Antibody |
| Clone: |
Polyclonal Antibodies |
| Concentration: |
1ug per 1ul |
| Antigen Source: |
BSA conjugated Chloramphenicol |
| Applications: |
IF(IHC-P) |
| Applications with corresponding dilutions: |
IF(IHC-P)(1:50-200) |
| Cross reactive species: |
Others |
| Cross Reactive Species details: |
Chloramphenicol |
| Background information: |
Due to resistance and safety concerns, In low-income countries, It was the first antibiotic to be manufactured synthetically on a large scale, although it is sometimes used topically for eye infections, and alongside the tetracyclines, and introduced into clinical practice in 1949, chloramphenicol is still widely used because it is exceedingly inexpensive and readily available, including most anaerobic organisms, is considered the prototypical broad-spectrum antibiotic, isolated by David Gottlieb, it is no longer a first-line agent for any indication in developed nations and has been replaced by newer drugs in this setting, Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae, Chloramphenicol is effective against a wide variety of Gram-positive and Gram-negative bacteria |
| Purification method: |
Purified by Protein A |
| Storage: |
50% glycerol and 0, Store at 4°, 09% sodium azide, C for 12 months, Water buffered solution containing 100ug/ml BSA |
| Excitation emission: |
590nm/617nm |
| Synonyms: |
Chloromycetin, D-&, D-&, D-threo-2, #8722, #8722, -threo-2, -threo-2-Dichloroacetamido-1-4-nitrophenyl-1, 2-Dichloro-N-[beta-hydroxy-alpha-hydroxymethyl-4-nitrophenethyl]acetamide, 2-Dichloro-N-[beta-hydroxy-alpha-hydroxymethyl-beta-4-nitrophenylethyl]acetamide, 3-propanediol, Chloramphenicol |
| Also known as: |
Chloramphenicol Polyclonal Antibody |
| Other name: |
Anti-Chloramphenicol Polyclonal |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, specificity and sensitivity, thus reducing its reactivity, Avoid freeze/thaw cycles as they may denaturate the polypeptide chains of the antibody |
| Properties: |
For facs or microscopy Alexa 1 conjugate |
| Conjugation: |
Alexa Fluor |
| Group: |
Polyclonals and antibodies |
| About: |
The advantage is that there are more epitopes available in a polyclonal antiserum to detect the proteins than in monoclonal sera, immunohistochemistry on frozen slices or parrafin fixed tissues, Polyclonals can be used for Western blot |
| Gene target: |
Chloramphenicol |
| Short name: |
Anti-Chloramphenicol (Polyclonal) Fluor 594 |
| Technique: |
Pabs are a collection of immunoglobulin , Polyclonal antibodies , each identifying a different , whereas , (pAbs) are mostly rabbit or goat , B cells, Polyclonal, antibodies , antigen, come from a single N cell lineage, epitope, molecules that react against a specific , monoclonal antibodies , that are secreted by different |
| Label: |
ALEXA |
| Alternative name: |
ALEXA Fluor 594, antibody to-Chloramphenicol (polyclonal) |
| Alternative technique: |
polyclonals |